BioSpace News Archive

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Tuesday, December 3, 2019, to provide top-line results from Part 1 of the adaptive Phase 3 RENEW Trial of topical ocular reproxalap in patients with dry eye disease.

Cerner Corporation, a global health care technology company, has achieved its 500th patent, a new innovative voice-assisted technology designed to make it easier for clinicians to document the details of a patient visit on a mobile device.

After a thorough and comprehensive review, the Canadian Food Inspection Agency cancelled three Safe Food for Canadian licences.

lagship Pioneering has announced the recipient of the firm’s annual Pioneering Leader Award

Nabriva Therapeutics plc, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced that it has granted non-statutory stock options to purchase an aggregate of 18,000 ordinary shares of Nabriva Therapeutics as inducements to 4 newly-hired employees.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that company founder Dr. Pamela Marrone will retire from her position as chief executive officer

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced that it has commenced an underwritten public offering of $75.0 million of shares of its common stock.

ViewRay, Inc. (Nasdaq: VRAY) announced today that it has signed a non-binding memorandum of understanding for collaboration with Elekta AB (Nasdaq: EKTA-B.ST) (“Elekta”) to advance the knowledge and use of MR-guided radiation therapy. In connection with the collaboration, Elekta has committed to invest capital for up to a 9.9% minority interest in ViewRay

Senseonics Holdings, Inc. (NYSE American: SENS) announced today that Eversense users who download the new Eversense® CGM mobile app can start dosing insulin based off of the readings from their Eversense System without the need to do a confirmatory blood glucose fingerstick measurement.

Recent data from the Centers for Disease Control and Prevention indicate that seasonal flu activity is increasing week over week, with cases reported in nearly all states.i As National Influenza Vaccination Week begins, CVS Health reminds customers that it is not too late to get a flu shot to protect themselves and their family members from the flu.